We conducted experiments on two pancreatic cancer cell lines, Mia PaCa‐2 and Panc‐1, both of which harbor common cancer‐related gene mutations, including KRAS, TP53, and CDKN2A. This evidence concerns the gene CDKN2A and cancer.